We evaluated the AQP4-IgG titers in 33 patients with AQP4-IgG-positive NMOSD, 30 with MOGAD, and 30 with MS, and in 120 healthy controls (Figure 5a,b). Here, AQP4 is linked to myeloid sarcoma.